强制令
发表于 2025-3-30 08:14:22
Cup-Tumore (Cancer of unknown primary),dure had vasospasm. Of the 70 clipped patients with vasospasm, 40 had mild vasospasm, 13 had moderate vasospasm, and 17 had severe vasospasm. All six patients treated by coils had moderate vasospasm. The average duration of vasospasm was 9 days (from 7 to 32 days)...: TCD was crucial for monitoring
有发明天才
发表于 2025-3-30 16:01:33
Strahlentherapeutische Aspekte, vs. 3.0 ± 0.6 pg/ml, . = 0.001). Lc counts did not differ (11.5 ± 0.5 vs. 11.2 ± 0.6 × 10./μl, . = 0.485). Patients with non-pmSAH stayed significantly longer in the neurocritical care unit (16.4 ± 2.1 vs. 10.2 ± 1.1 days, . = 0.012). Symptomatic CVS occurred in two patients with non-pmSAH. Patient
种子
发表于 2025-3-30 18:47:05
Eberhard Schäfer,Stefan Kircher,Ferenc Nagyscore (. = 0.016), but IAF was significantly correlated with GOS (. = 0.035). By multiple regression analysis, Hunt and Kosnik grade and CT score significantly correlated with GOS...: CT score significantly correlated with functional outcome. Although IAF, both selective and nonselective, was signif
Formidable
发表于 2025-3-30 23:58:44
http://reply.papertrans.cn/23/2234/223324/223324_54.png
背景
发表于 2025-3-31 03:19:23
http://reply.papertrans.cn/23/2234/223324/223324_55.png
CON
发表于 2025-3-31 06:16:16
,Frank H. Mayfield, MD, FACS, FAANS (1909–1991): 75th Anniversary Tribute,inspired solutions to the devastating problems of cerebral vasospasm after subarachnoid hemorrhage (SAH). This conference proceedings, .: ...., is dedicated to Dr. Mayfield, a University of Cincinnati professor and pioneer in neurosurgery who directed the graduate neurosurgical training programs at
Jargon
发表于 2025-3-31 13:03:39
http://reply.papertrans.cn/23/2234/223324/223324_57.png
Morose
发表于 2025-3-31 15:47:01
http://reply.papertrans.cn/23/2234/223324/223324_58.png
英寸
发表于 2025-3-31 19:06:38
http://reply.papertrans.cn/23/2234/223324/223324_59.png
推迟
发表于 2025-3-31 23:02:26
Global Cerebral Atrophy After Subarachnoid Hemorrhage: A Possible Marker of Acute Brain Injury and as investigated the impact of global brain atrophy on outcome after SAH. In other neurological disorders, such as multiple sclerosis, a correlation has been found between global atrophy and outcome. This analysis of patients entered into a randomized clinical trial of clazosentan in patients with SA